This study, called SUMMIT RISE, is looking at how well a device called the Route 92 Medical Reperfusion Systems works for people who have had an acute ischemic stroke (a stroke caused by a blood clot blocking blood flow to the brain). The device is used during a procedure called mechanical thrombectomy, which removes the clot. The study wants to see how well the device reopens blood vessels during the procedure. You might be able to join if you are at least 18 years old, had an acute ischemic stroke, and were treated with the Route 92 Medical Reperfusion System within 8 hours of when your stroke symptoms started. The study aims to enroll 500 participants.

Study design

This interventional study plans to enroll 500 participants. It is evaluating a medical device for acute ischemic stroke patients.

What's involved

You would need to provide informed consent within 72 hours after your thrombectomy procedure.

Compensation

Not stated in the trial record.

Follow-up

The primary outcome of blood vessel reopening is measured during the procedure.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.